Natco Pharma Board to Consider Fund Raising on 9th Sep'26
Natco Pharma Ltd 路 Intimation 路 05 Sept 2026, 12:39 am
Natco Pharma Board to Consider Fund Raising on 9th Sep'26 Natco Pharma Limited has scheduled a Board of Directors meeting on 9th Sep'26 to consider and evaluate proposals for fund raising. The capital raise may be executed through the issuance of equity shares or other permitted securities, subject to necessary statutory and regulatory approvals.
Original exchange filing (PDF)
More announcements from Natco Pharma Ltd
- Intimation of Investor Meet 路 17 Nov 2026
- Audio link of Earnings Conference Call Q2FY27 路 14 Nov 2026
- Q2 FY27 Earnings Presentation 路 13 Nov 2026
- Un audited Financial Results for the quarter and half year ended 30th September, 2026 路 13 Nov 2026
- 19th November, 2026 is the Record Date for the payment of 2nd Interim Dividend for FY 2026-27 路 13 Nov 2026
- Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026 and declaration of 2nd Interim Dividend for FY 2026-27 路 13 Nov 2026
- Outcome of Board Meeting 路 13 Nov 2026
- Intimation of schedule of Concall 路 13 Nov 2026
